Dublin, December 31, 2020 (GLOBE NEWSWIRE) – The “Antibodies Market Research and Product-Based Antibodies {Antibodies [Type (Primary, Secondary), Production, Source, Research Area (Oncology, Neurology)], Feedback}, Technology (ELISA, Western Blot), Application, End User (Pharma, Academia) – Global Forecast to 2027. “Report Added ResearchAndMarkets.com’s offering.
The research and reaction antibodies market is expected to grow at a CAGR of 5.6% from 2020 to 2027 to reach USD 6.32 billion by 2027.
Factors such as increased demand for protein therapy & personalized therapy, increased investment in stem cell research, and increased need for biomarker identification represent high growth opportunities for players over the expected period. However, factors such as high cost and time associated with identifying and developing antibodies are expected to contribute that may hinder the growth of this market.
In 2020, based on the type, the antibodies sector is expected to account for the largest share of this market. The large proportion of this segment is largely due to a growing demand for antibodies for biochemical analysis, a growing focus on protein and cell-based research, and increasing biomarker detection.
On the basis of technology, by 2020, the flow cytometry sector is ready to control the largest share of the market of research and feedback antibodies. Growing biomedical research for better diagnosis and treatment, emerging biomarker detection initiatives, and growing cell & molecular-based research are the factors driving this growth.
By 2020, the proteomics sector is expected to dominate the largest share of the research and feedback antibodies market. A growing focus on protein-based research and the growing need for effective drugs using different protein-based disease profiles are the factors driving the growth of this segment.
The pharmaceutical and biotechnology industry widely accepts research antibodies and reactions for proteomics study and drug discovery and development.
An in-depth study of the geographic position of research antibodies market and feedback provides detailed qualitative and qualitative insights for the five major regions (North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa) along with the coverage of major countries in each region. In 2020, North America is projected to control the largest share of the antibodies and research reactions market, followed by Europe, Asia-Pacific, Latin America, and the Middle East & Africa.
Key topics covered:
1. Introduction
1.1. Market ecosystem
1.1.1. Antibodies and Reagents Market Research
1.1.2. Antibodies and Reagents Market Research, by Product
1.2. Money and Restrictions
1.3. Key stakeholders
2. Research Methodology
2.1. Research Process
2.1.1. Secondary Research
2.1.2. Primary Research
3. Executive Minutes
4. Market views
4.1. Introduction
4.2. Market dynamics
4.2.1. Drivers
4.2.1.1. Proteomics and Genomics Research Studies on the rise
4.2.1.2. Increase in funding for research activities
4.2.1.3. Growing Business-Academia Collaboration
4.2.2. Obstruction
4.2.2.1. High cost and time associated with identification and development of potential antibodies
4.2.3. Opportunities
4.2.3.1. Rising demand for protein therapy and personalized medications
4.2.3.2. Rising investment and focus on stem cell research
4.2.3.3. Emerging need for new biomarker identification
4.2.3.4. Significant opportunities from Asia-Pacific and Latin-American crisis markets
4.2.4. Challenges
4.2.4.1. Issues Relating to the Quality and Sustainability of Research Antibodies
4.2.4.2. Intense price pressure on key players
5. Antibodies and Reagents Market Research, by Product
5.1. Introduction
5.2. Antibodies
5.2.1. Market antibodies, by type
5.2.1.1. Primary antibodies
5.2.1.2. Antibody High School
5.2.2. Market antibodies, by type of production
5.2.2.1. Monoclonal antibody
5.2.2.2. Polyclonal antibody
5.2.2.3. Antibody particles
5.2.3. Antibody Market, according to a source
5.2.3.1. Mouse
5.2.3.2. Rabbit
5.2.3.3. Other sources
5.2.4. Market antibodies, according to research area
5.2.4.1. Oncology
5.2.4.2. Infectious diseases
5.2.4.3. Cardiovascular disease
5.2.4.4. Psychology
5.2.4.5. Neurology
5.2.4.6. Stem Cell Research
5.2.4.7. Other Areas of Research
5.3. Feedback
5.3.1. Sample preparation reactions
5.3.1.1. Media and Serum
5.3.1.2. Stains and Dyes
5.3.1.3. Probes
5.3.1.4. Buffers
5.3.1.5. Solutions
5.3.2. Antibody production reactions
5.3.2.1. Enzymes
5.3.2.2. Proteins
5.3.3. Other research feedback
6. Antibodies and Reagents Market Research, by Technology
6.1. Introduction
6.2. Flow cytometry
6.3. Immunofluorescence
6.4. Immunosorbent-Enzyme-Linked Assay
6.5. Immunoprecipitation (IP)
6.6. Assay Immunosorbent Multiplex
6.7. Immunohistochemistry
6.8. Western Blot
6.9. Other technologies
7. Antibodies and Reagents Market Research, by Demand
7.1. Introduction
7.2. Proteomics
7.3. Detection and development of drugs
7.4. Genomics
8. Antibodies and Reagents Market Research, by End User
8.1. Introduction
8.2. Pharmaceutical and Biotechnology Industry
8.3. Academic and Research Institutes
8.4. Contract Research Organizations
9. Antibodies and Reagents Market Research, by Geography
10. Competitive Landscape
10.1. Introduction
10.2. Key Growth Strategies
10.3. Competitive competitive tokens
10.4. Market segment analysis
11. Company Profiles
11.1. Business overview
11.2. Financial overview
11.3. Fruit pack
- GE Healthcare (US)
- Merck KGaA (Germany)
- Thermo Fisher Scientific Inc. (US)
- F. Hoffmann La-Roche AG (Switzerland)
- Rockland Immunochemicals Inc. (US)
- Johnson & Johnson (US)
- Agilent Technologies Inc. (US)
- Eli Lily and Company (USA)
- Becton Dickinson and Company (USA)
- Danaher Corporation (US)
- PerkinElmer Inc. (US)
- GenScript Biotech Corporation (US)
- Lonza (Switzerland)
- Corporate Bio-Techne (US)
- Bio-Rad Laboratories Inc. (US)
- Teva Pharmaceutical Industries Limited (Israel)
- Santa Cruz Biotechnology Inc. (US)
- BioLegend Inc. (US)
For more information about this report, visit https://www.researchandmarkets.com/r/q5a7ww
Research and Markets also offers Custom Search services providing targeted, complete and unique search.
CONTACT: ResearchAndMarkets.com Laura Wood, Senior Press Manager [email protected] For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900